Search Results

• • 89 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling.

  Authors:Jiayao Lei, Mark Clements, Miriam Elfström, Kalle Conneryd Lundgren, and Joakim DillnerFrom:PLoS ONE (Vol. 17, Issue 8) Peer-Reviewed

  Aug. 12, 20224,556 words Report 1600LBackground Prediction of SARS-CoV-2-induced sick leave among healthcare workers (HCWs) is essential for being able to plan the healthcare response to the epidemic. Methods During first wave of the SARS-Cov-2...

• Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment.

  Authors:Konstantinos S. Kechagias, Ilkka Kalliala, Sarah J. Bowden, Antonios Athanasiou, Maria Paraskevaidi, Evangelos Paraskevaidis, et al.From:British Medical Journal (Vol. 378, Issue 8348) Peer-Reviewed

  Aug. 6, 202254 words Report

   Citation Only

• Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study.

  Authors:Daniel J Sheward, Changil Kim, Roy A Ehling, Alec Pankow, Xaquin Castro Dopico, Robert Dyrdak, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 6) Peer-Reviewed

  June 2022508 words Article

   Abstract Only

• Sirum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer

  Authors:Jorma Paavonen, Karuna P. Karunakaran, Yasuyuki Noguchi, Tarja Anttila, Aini Bloigu, Joakim Dillner, et al.From:American Journal of Obstetrics and Gynecology (Vol. 189, Issue 5) Peer-Reviewed

  Nov. 2003 Article

   Citation Only

• Near full control of human papillomavirus vaccine types

  Author:Joakim DillnerFrom:The Lancet Infectious Diseases (Vol. 15, Issue 11) Peer-Reviewed

  Nov. 201538 words Article

   Abstract Only

• Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial

  Authors:Caroline Lilliecreutz, Hanna Karlsson, Anna-Clara Spetz Holm, and Joakim DillnerFrom:PLoS ONE (Vol. 15, Issue 7) Peer-Reviewed

  July 2, 20206,089 words Report 1450LAuthor(s): Caroline Lilliecreutz *, Hanna Karlsson, Anna-Clara Spetz Holm Introduction In Sweden, 559 new cases of cervical cancer were identified in 2017, i.e. 11.2 cases per 100 000 women [1]. However, cervical...

• Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma

  Authors:Ola Forslund, Thomas Iftner, Kristin Andersson, Bernt Lindelof, Eva Hradil, Peter Nordin, et al.From:Journal of Infectious Diseases (Vol. 196, Issue 6) Peer-Reviewed

  Sept. 15, 2007 Clinical report

   Citation Only

• Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

  Authors:Jose Mario Sabio, Juan opasquau, Juan Jimenez-Alonso, Jens Peter Klussmann, Soenke Weissenborn, Pawel G. Fuchs, et al.From:The New England Journal of Medicine (Vol. 345, Issue 5) Peer-Reviewed

  Aug. 2, 2001 Letter to the editor

   Citation Only

• Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens

  Authors:Kristina Elfgren, Peter Bistoletti, Lena Dillner, Jan M.M. Walboomers, Chris J.L.M. Meijer, and Joakim DillnerFrom:American Journal of Obstetrics and Gynecology (Vol. 174, Issue 3) Peer-Reviewed

  Mar. 1996112 words Article

   Abstract Only

• Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study

  Authors:Iacopo Baussano, Fulvio Lazzarato, Guglielmo Ronco, Matti Lehtinen, Joakim Dillner, and Silvia FranceschiFrom:Journal of Infectious Diseases (Vol. 216, Issue 3) Peer-Reviewed

  Aug. 1, 2017 Report

   Citation Only

• Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination

  Authors:Tuomas Lehtinen, Anna Soderlund-Strand, Tiina Petaja, Tiina Eriksson, Sakari Jokiranta, Kari Natunen, et al.From:Journal of Infectious Diseases (Vol. 216, Issue 8) Peer-Reviewed

  Oct. 15, 2017 Report

   Citation Only

• Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model

  Authors:Inge M.C.M. de Kok, Joost van Rosmalen, Joakim Dillner, Marc Arbyn, Peter Sasieni, Thomas Iftner, et al.From:British Medical Journal (Vol. 344, Issue 7847) Peer-Reviewed

  Mar. 10, 201262 words Report

   Citation Only

• Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia

  Authors:Matti Lehtinen, Kevin A. Ault, Erika Lyytikainen, Joakim Dillner, Suzanne M. Garland, Daron G. Ferris, et al.From:Sexually Transmitted Infections (Vol. 87, Issue 5) Peer-Reviewed

  Aug. 2011 Report

   Citation Only

• Ethical framework for previously collected biobank samples

  Authors:Gert Helgesson, Joakim Dillner, Joyce Carlson, Claus R Bartram, and Mats G HanssonFrom:Nature Biotechnology (Vol. 25, Issue 9) Peer-Reviewed

  Sept. 20072,329 words Article Author(s): Gert Helgesson [1]; Joakim Dillner [2]; Joyce Carlson [3]; Claus R Bartram [4]; Mats G Hansson [1] To the editor: An increasing trend in biobank research is to pool collections of biological samples in...

• Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck

  Authors:Jon Mork, A. Kathrine Lie, Eystein Glattre, Goran Hallmans, Egil Jellum, Pentti Koskela, et al.From:The New England Journal of Medicine (Vol. 344, Issue 15) Peer-Reviewed

  Apr. 12, 200150 words Article

   Citation Only

• HPV Vaccination and the Risk of Invasive Cervical Cancer.

  Authors:Jiayao Lei, Alexander Ploner, K. Miriam Elfstrom, Jiangrong Wang, Adam Roth, Fang Fang, et al.From:The New England Journal of Medicine (Vol. 383, Issue 14) Peer-Reviewed

  Oct. 1, 202035 words Clinical report

   Citation Only

• Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysis

  Author:Joakim DillnerFrom:Clinical Chemistry (Vol. 51, Issue 10) Peer-Reviewed

  Oct. 20051,351 words Article 1540L

   Citation Only

• The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study

  Authors:Eva Herweijer, Adina L. Feldman, Alexander Ploner, Lisen Arnheim-Dahlstrom, Ingrid Uhnoo, Eva Netterlid, et al.From:PLoS ONE (Vol. 10, Issue 7) Peer-Reviewed

  July 28, 20155,022 words Article 1530LBackground Concerns have been raised that HPV-vaccination might affect women's cervical screening behavior. We therefore investigated the association between opportunistic HPV-vaccination and attendance after...

• A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage

  Authors:Pontus Bjerre, Lena Silfverdal, Lena Dillner, BjoRn Hagmar, Henrik Edvardsson, Joakim Dillner, et al.From:American Journal of Obstetrics and Gynecology (Vol. 199, Issue 1) Peer-Reviewed

  July 2008215 words Clinical report

   Abstract Only

• Serotypes of Chlamydia trachomatis and Risk for Development of Cervical Squamous Cell Carcinoma

  Authors:Tarja Anttila, Pekka Saikku, Pentti Koskela, Aini Bloigu, Joakim Dillner, Irma Ikaheimo, et al.From:JAMA, The Journal of the American Medical Association (Vol. 285, Issue 1) Peer-Reviewed

  Jan. 3, 200140 words Article

   Abstract Only